Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy R Cross

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Transplantation|February 23, 2023
IL-21-producing Alloreactive T Cells Expand in Parallel to Donor-specific AntibodiesFadi Issa, Amy R Cross
Transplantation|March 22, 2023
Opportunities for High-plex Spatial Transcriptomics in Solid Organ TransplantationAmy R Cross, Lisa Gartner, Joanna Hester, et al.
Transplantation|February 19, 2020
Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative MedicineGeorge Adigbli, Séverine Ménoret, Amy R Cross, et al.
Kidney International|July 17, 2019
HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3<sup>high</sup> regulatory T lymphocytesAmy R Cross, Julien Lion, Karine Poussin, et al.
Human Immunology|April 10, 2016
Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and QsAmy R Cross, Julien Lion, Pascale Loiseau, et al.
Med (New York, N.Y.)|December 28, 2024
Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplantsOliver McCallion, Amy R Cross, Matthew O Brook, et al.
JCI Insight|December 6, 2022
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injuryAmy R Cross, Carlos E de Andrea, María Villalba-Esparza, et al.
Journal of Hepatology|September 10, 2022
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humansTiong Y Lim, Elena Perpiñán, Maria-Carlota Londoño, et al.
Nature Genetics|November 5, 2021
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locusDamien J Downes, Amy R Cross, Peng Hua, et al.
Cell Reports|October 19, 2022
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protectionDerek VanDyke, Marcos Iglesias, Jakub Tomala, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Transplantation|February 23, 2023
IL-21-producing Alloreactive T Cells Expand in Parallel to Donor-specific AntibodiesFadi Issa, Amy R Cross
Transplantation|March 22, 2023
Opportunities for High-plex Spatial Transcriptomics in Solid Organ TransplantationAmy R Cross, Lisa Gartner, Joanna Hester, et al.
Transplantation|February 19, 2020
Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative MedicineGeorge Adigbli, Séverine Ménoret, Amy R Cross, et al.
Kidney International|July 17, 2019
HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3<sup>high</sup> regulatory T lymphocytesAmy R Cross, Julien Lion, Karine Poussin, et al.
Human Immunology|April 10, 2016
Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and QsAmy R Cross, Julien Lion, Pascale Loiseau, et al.
Med (New York, N.Y.)|December 28, 2024
Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplantsOliver McCallion, Amy R Cross, Matthew O Brook, et al.
JCI Insight|December 6, 2022
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injuryAmy R Cross, Carlos E de Andrea, María Villalba-Esparza, et al.
Journal of Hepatology|September 10, 2022
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humansTiong Y Lim, Elena Perpiñán, Maria-Carlota Londoño, et al.
Nature Genetics|November 5, 2021
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locusDamien J Downes, Amy R Cross, Peng Hua, et al.
Cell Reports|October 19, 2022
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protectionDerek VanDyke, Marcos Iglesias, Jakub Tomala, et al.
Pageof 1